Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Stephen Melnick, Priya Rajagopalan, Theresa Lynn, Anthony Donato
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Greater Baltimore Medical Center 2018-09-01
Sarja:Journal of Community Hospital Internal Medicine Perspectives
Aiheet:
Sodium glucose co-transporter inhibitor
SGLT2 inhibitor
genitourinary infections
Linkit:http://dx.doi.org/10.1080/20009666.2018.1527667

Internet

http://dx.doi.org/10.1080/20009666.2018.1527667

Samankaltaisia teoksia